Invented name part: Equilidem
Strength name part: 2.5 mg
Pharmaceutical dose form name part: film-coated tablets
Country: EU (http://ema.europa.eu/fhir/countryCode)
Language: EN (http://ema.europa.eu/fhir/languageCode)
Identifier: {mpid} (http://ema.europa.eu/fhir/MPID)
Legal Status of Supply: Subjecttomedicalprescription (http://ema.europa.eu/fhir/legalstatusofsupply)
Classification: WHOAnatomicalTherapeuticChemicalATCClassificationSystem|B01AF02 (http://ema.europa.eu/fhir/WHOAnatomicalTherapeuticChemicalATCClassificationSystem)
OperationType: Batchrelease (http://ema.europa.eu/fhir/manufacturingOperationType)
Date: from 2013-03-15
Organization:
Identifier:
Equilidem2-5mg-organization (https://spor.ema.europa.eu/v1/locations)
Marketing StatusCountry: EU (http://ema.europa.eu/fhir/countryCode)
Status: Marketed (http://ema.europa.eu/fhir/marketingstatus)
Date: 2010-05-26
Master File
Document (failed to find DocumentReference reference Equilidem2-5mg-d3e690 in the Bundle)